IOMAR CAMACHO-ALVAREZ: Open Payments
NPI 1861014268 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 61 payments from 19 companies in 2025. Trend: 2023 $904 · 2024 $1,365 · 2025 $1,100
Food & beverage: $1,100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $297 |
| Novo Nordisk Inc | 7 | $129 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Neurelis, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $41 |
Products named: UBRELVY, VRAYLAR, Wegovy, MOUNJARO, TRELEGY ELLIPTA, Kerendia, AUSTEDO XR, VALTOCO.
Industry payments across MI — which companies pay providers there.
